Aastrom says FDA lifts stem cell trial halt
NEW YORK — Aastrom Biosciences Inc., which develops adult stem cells to treat heart diseases, said Thursday the Food and Drug Administration has lifted a halt on a clinical trial. Aastrom said it will...
View ArticleExperts dispute doctor’s stem cell breakthrough claim
6/15/09 The Food and Drug Administration has not approved this stem cell therapy in the United States because no clinical trials to prove its effectiveness have been done. But Dr. Zannos Grekos says...
View ArticleFDA Public Health Notification: Vista Cord, LLC
9/25/09 The Food and Drug Administration (FDA) is issuing this notification to inform the health care community and the public that Vista Cord, LLC (Vista Cord), a registered establishment that...
View ArticleAdvanced Cell Technology Provides Update on Clinical Trials Using Embryonic...
1/8/10 WORCESTER, Mass.–(BUSINESS WIRE)– Advanced Cell Technology, Inc. (OTCBB:ACTC), a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that it...
View ArticleFDA Gives TCA Cellular Therapy Green Light to Proceed with First ALS Adult...
1/13/10 TCA Cellular Therapy, LLC (TCA-CT) announced today that the U.S. Food and Drug Administration (FDA) has approved its adult stem cell protocol to conduct Phase I clinical trials to treat...
View ArticleFirst FDA-Approved Stem Cell Trial in Pediatric Cerebral Palsy
2/11/10 ScienceDaily (Feb. 11, 2010) — Medical College of Georgia researchers are conducting the first FDA-approved clinical trial to determine whether an infusion of stem cells from umbilical cord...
View Article